Abstract:Introduction Bone marrow mesenchymal stem cells (BMSCs) possess low immunogenicity and immunosuppression as an allograft, can differentiate into insulin-producing cells (IPCs) by in vitro induction, and may be a valuable cell source to regenerate pancreatic islets. However, the very low differentiation efficiency of BMSCs towards IPCs under adherent induction has thus far hindered the clinical exploitation of these cells. The aim of this study is to explore a new way to efficiently induce BMSCs into IPCs and lay the groundwork for their clinical exploitation. Methods In comparison with adherent induction, BMSCs of human first-trimester abortus (hfBMSCs) under a nonadherent state were induced towards IPCs in noncoated plastic dishes using a three-stage induction procedure developed by the authors. Induction effects were evaluated by statistics of the cell clustering rate of induced cells, and ultrastructural observation, dithizone staining, quantitative polymerase chain reaction and immunofluorescence assay, insulin and c-peptide release under glucose stimulus of cell clusters, as well as transplantation test of the cell clusters in diabetic model mice. Results With (6.175 ± 0.263) × 10 5 cells in 508.5 ± 24.5 cell clusters, (3.303 ± 0.331) × 10 5 single cells and (9.478 ± 0.208) × 10 5 total cell count on average, 65.08 ± 2.98% hfBMSCs differentiated into pancreatic islet-like cell clusters after nonadherent induction. With (3.993 ± 0.344) × 10 5 cells in 332.3 ± 41.6 cell clusters, (5.437 ± 0.434) × 10 5 single cells and (9.430 ± 0.340) × 10 5 total cell count on average, 42.37 ± 3.70% hfBMSCs differentiated into pancreatic islet-like cell clusters after adherent induction ( P < 0.01, n = 10). The former is significantly higher than the latter. Calculated according to the cell clustering rate and IPC percentage in the cell clusters, 29.80 ± 3.95% hfBMSCs differentiated into IPCs after nonadherent induction and 18.40 ± 2.08% hfBMSCs differentiated into IPCs after adherent induction ( P < 0.01, n = 10), the former significantly higher than the latter. The cell clusters expressed a broad gene profile related to pancreatic islet cells, released insulin and c-peptide in a glucose concentration-dependent manner, and normalized hyperglycemia of streptozocin-induced mice for at least 80 days following xenograft. Blood glucose of grafted mice rose again after their graft removed. A series of examination of the grafts showed that transplanted cells produced human insulin in recipients. Conclusions Our studies demonstrate that nonadherent induction can greatly promote BMSCs to form pancreatic islet-like cell clusters, thereby improving the differentiation efficiency of BMSCs towards IPCs.

In vitro generation of functional insulin-producing cells from human bone marrow-derived stem cells, but long-term culture running risk of malignant transformation.

In Vivo And In Vitro Characterization Of Insulin-Producing Cells Obtained From Murine Bone Marrow

In Vitro Expansion of Pancreatic Islet Clusters Facilitated by Hormones and Chemicals.

IN VITRO TRANSDIFFERENTIATION OF RAT BONE MARROW MESENCHYMAL STEM CELLS INTO INSULIN-SECRETING CELLS

Generation of Insulin-Producing Cells from PDX-1 Gene-Modified Human Mesenchymal Stem Cells.

Human bone marrow mesenchymal stem cells differentiate into insulin-producing cells upon microenvironmental manipulation in vitro.

Generation of Insulin-Producing Cells from PDX1 and NKX6.1 Gene-Modified Bone Marrow Mesenchymal Stem Cells

Insulin-Producing Cells Differentiated from Human Bone Marrow Mesenchymal Stem Cells in Vitro Ameliorate Streptozotocin-Induced Diabetic Hyperglycemia

Generation of Insulin-Producing Cells from Bone Marrow Mesenchymal Stem Cells with Modified Expression of PDX1 and NKX6.1

Differentiation of bone marrow mesenchymal stem cells into insulin-producing cells: A dynamic observation

Insulin-Secreting Cells Differentiation Derived from Human Embryonic Germ Cells

In vitro derivation of functional insulin-producing cells from human embryonic stem cells

Direct Differentiation of Bone Marrow Mononucleated Cells Into Insulin-Producing Cells Using 4 Specific Soluble Factors

Cultivation, Identification and Islet β Cells Induction of Bone Marrow Mesenchymal Stem Cells in Rats

Pancreatic Islet-Like Clusters from Bone Marrow Mesenchymal Stem Cells of Human First-Trimester Abortus Can Cure Streptozocin-Induced Mouse Diabetes.

Generation of Functional Insulin-Producing Cells from Human Embryonic Stem Cells in Vitro

Progress in Treating Diabetes Mellitus with Adult Stem Cells

Under a nonadherent state, bone marrow mesenchymal stem cells can be efficiently induced into functional islet-like cell clusters to normalize hyperglycemia in mice: a control study

Strategies to Improve the Safety of iPSC-Derived β Cells for β Cell Replacement in Diabetes

In Vitro Cultivation of Islet-Like Cell Clusters from Human Umbilical Cord Blood-Derived Mesenchymal Stem Cells

Effective Generation of Functional Pancreatic β Cells from Human-Derived Dental Stem Cells of Apical Papilla and Bone-Marrow-Derived Stem Cells: A Comparative Study